Cart
sales@molnova.com
Fipexide
CAS No. 34161-24-5
Fipexide( —— )
Catalog No. M14159 CAS No. 34161-24-5
Fipexide (Attentil, Vigilor) is a psychoactive drug of the piperazine chemical class which was developed in Italy in 1983.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 28 | In Stock |
|
| 50MG | 37 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 200MG | 68 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFipexide
-
NoteResearch use only, not for human use.
-
Brief DescriptionFipexide (Attentil, Vigilor) is a psychoactive drug of the piperazine chemical class which was developed in Italy in 1983.
-
DescriptionFipexide (Attentil, Vigilor) is a psychoactive drug of the piperazine chemical class which was developed in Italy in 1983. It was used as a nootropic drug in Italy and France, mainly for the treatment of senile dementia, but is no longer in common use due to the occurrence of rare adverse drug reactions including fever and hepatitis.
-
In Vitro——
-
In VivoAnimal Model:Kindled rats Dosage:10 mg/kg Administration:Orally; 5-10 days Result:Completely abolishes the memory deficit produced by kindling. Antagonized the amnestic effect of Pentylenetetrazole (PTZ) -kindling.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number34161-24-5
-
Formula Weight388.85
-
Molecular FormulaC20H21ClN2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESClC1=CC=C(OCC(=O)N2CCN(CC3=CC4=C(OCO4)C=C3)CC2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Marino A, et al. Pharmacol Res. 1990 Mar-Apr;22(2):179-87.
molnova catalog
related products
-
Tetrabenazine
Tetrabenazine is a VMAT-inhibitor used for treatment of hyperkinetic movement disorder.
-
Perphenazine dihydro...
Perphenazine dihydrochloride is an orally active dopamine receptor and histamine-1 receptor antagonist that acts on D2 (Ki: 0.56 nM), D3 (Ki: 0.43 nM), and 5-HT2A (Ki: 0.6 nM) receptors, and also binds Alpha-1A adrenergic receptors.
-
CCT241736
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3.
